Key to making personalized medicine a reality, companion diagnostics are playing a critical role in the accurate diagnosis of disease and are enabling the efficient use of targeted therapies. This highly complex sector continues to innovate, as exemplified by the development of liquid biopsy technology, which introduces a new, noninvasive, cost-effective way for clinicians to make treatment adjustments.
Robert Hunter recently joined the BCC Research Editorial team as a new Senior Editor, Healthcare. He is the author of Companion Diagnostics: Technologies and Markets. We recently asked him a few questions about his latest report.